Department of Physiotherapy, Institute of Health Sciences, College of Medical Sciences, University of Rzeszów, Rzeszów.
Department of Physiotherapy, Institute of Health Sciences, College of Medical Sciences, University of Rzeszów, Rzeszów.
Arch Phys Med Rehabil. 2021 Feb;102(2):175-184. doi: 10.1016/j.apmr.2020.10.122. Epub 2020 Nov 9.
To assess effects of 15 exoskeleton-assisted gait training sessions, reflected by the muscle strength of the lower limbs and by walking speed immediately after the training sessions and at the 6-week follow-up.
Single-group longitudinal preliminary study.
Individuals with multiple sclerosis (MS) at a hospital neurology ward.
Participants (N=14) included women and men aged from 36-61 years, with Expanded Disability Status Scale scores from 5.0-6.5.
Exoskeleton-assisted walk training.
Primary outcomes included dynamometric knee extensor and flexor strength (Biodex Pro4), postural balance, and center of pressure displacements (Zebris FMD-S). Secondary outcomes included walking speed measured with the timed 25-foot walk test and fatigue (Fatigue Severity Scale). Assessments were performed 4 times, that is, prior to the start of the program (T0), at the end of the physiotherapy without an exoskeleton (T1), at the end of the exoskeleton-assisted training (T2), and at 6-week follow-up (T3).
At the end of exoskeleton-assisted gait training there was a statistically significant improvement in peak torque of knee extensor muscles compared with the period of exercise without an exoskeleton. No statistically significant change was identified in the value of peak torque of knee flexors at T1. Likewise, the assessment at T2 showed the change in peak torque of knee flexors was not significant. The participants presented significantly faster walking speed after exoskeleton-assisted gait training compared with T0 and T1. No improvement was found in body balance. The subjects reported lower fatigue after exoskeleton-assisted gait training; however, the differences between the assessments at T1 and T0 as well as at T2 and T1 were statistically insignificant.
Individuals with MS and severe gait impairment participating in exoskeleton-assisted gait training achieved significant improvement in lower-limb muscle strength and increase in walking speed, yet the effect was not long-lasting.
评估 15 次外骨骼辅助步态训练的效果,包括下肢肌肉力量以及训练结束后即刻和 6 周随访时的步行速度。
单组纵向初步研究。
医院神经内科病房的多发性硬化症(MS)患者。
纳入年龄 36-61 岁、扩展残疾状况量表(EDSS)评分 5.0-6.5 的女性和男性参与者共 14 名。
外骨骼辅助步行训练。
主要结局指标包括测力膝关节伸肌和屈肌力量(Biodex Pro4)、姿势平衡和中心压力位移(Zebris FMD-S)。次要结局指标包括计时 25 英尺步行测试和疲劳(疲劳严重程度量表)测量的步行速度。评估共进行了 4 次,即在方案开始前(T0)、无外骨骼的物理治疗结束时(T1)、外骨骼辅助训练结束时(T2)和 6 周随访时(T3)。
在外骨骼辅助步态训练结束时,与无外骨骼的运动期间相比,膝关节伸肌的峰值扭矩有统计学意义的改善。在 T1 时,膝关节屈肌的峰值扭矩值没有统计学意义的变化。同样,T2 的评估结果显示,膝关节屈肌的峰值扭矩变化不显著。与 T0 和 T1 相比,参与者在外骨骼辅助步态训练后行走速度显著加快。身体平衡没有改善。在接受外骨骼辅助步态训练后,患者报告疲劳感降低;然而,T1 与 T0 以及 T2 与 T1 之间的评估差异无统计学意义。
患有 MS 且严重步态障碍的患者参加外骨骼辅助步态训练可显著改善下肢肌肉力量并提高步行速度,但效果不持久。